Literature DB >> 10575368

Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells.

K Schmidt1, R Gust, M Jung.   

Abstract

Inhibitors of histone deacetylase are attracting increasing interest due to their influence on transcription, differentiation, and apoptosis. We have investigated two synthetic inhibitors 3 and 4 of histone deacetylase and the natural product inhibitor trichostatin A for their ability to suppress the growth of MCF-7 breast cancer cells and here present complete and improved synthetic procedures. The compounds show a dose dependent inhibition of growth with activities in the low micromolar and nanomolar range. Trichostatin shows cytocidal effects at 100 nM and still has activity comparable to cisplatin (0.5 microM) at 10 nM. Whereas the synthetic inhibitor 3 has cytocidal activity at 10 microM compound 4 shows a maximum of 40% growth suppression at that concentration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10575368     DOI: 10.1002/(sici)1521-4184(199910)332:10<353::aid-ardp353>3.0.co;2-x

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  6 in total

1.  Induction of human gamma globin gene expression by histone deacetylase inhibitors.

Authors:  Hua Cao; George Stamatoyannopoulos; Manfred Jung
Journal:  Blood       Date:  2003-08-14       Impact factor: 22.113

2.  Induction of apoptosis by Trichostatin A in human breast cancer cell lines: involvement of 15-Lox-1.

Authors:  Masoumeh Tavakoli-Yaraki; Fatemeh Karami-Tehrani; Vahid Salimi; Majid Sirati-Sabet
Journal:  Tumour Biol       Date:  2012-10-06

3.  Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells.

Authors:  Yehua Gan; Jian Wang; Joseph Coselli; Xing Li Wang
Journal:  Biochem Biophys Res Commun       Date:  2007-11-09       Impact factor: 3.575

Review 4.  Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines.

Authors:  Jürgen Sonnemann; Jennifer Gänge; K Saravana Kumar; Cornelia Müller; Peter Bader; James F Beck
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.850

5.  Proliferation rate of somatic cells affects reprogramming efficiency.

Authors:  Yongyu Xu; Xiaoyuan Wei; Min Wang; Ru Zhang; Yanbin Fu; Mingzhe Xing; Qiuhong Hua; Xin Xie
Journal:  J Biol Chem       Date:  2013-02-25       Impact factor: 5.157

6.  Trichostatin A targets the mitochondrial respiratory chain, increasing mitochondrial reactive oxygen species production to trigger apoptosis in human breast cancer cells.

Authors:  Shujuan Sun; Yingyan Han; Jia Liu; Yong Fang; Yuan Tian; Jianfeng Zhou; Ding Ma; Peng Wu
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.